Information on drugs and medical devices (including ones under development) appearing in this integrated report is provide as part of corporate disclosure, not for such purposes as promotion, advertising, or provision of medical advice.
Management message
To fulfill our mission
as a corporate group
trusted by society
Representative Director, Chairman, and President Mitsuo Sawai explains recurrence prevention measures in response to inappropriate testing at Sawai Pharmaceutical as well as future growth initiatives.
Our value creation story
Always putting
healthier lives first
With the generic drug business at the center of our operations, we will mobilize the strengths of all Group employees to continue taking on challenges to contribute to the health of as many people as possible.
- Our value creation model
- Sawai Group’s strengths
- Sustainability at the Sawai Group
- Financial and non-financial highlights
Value creation strategy
New growth strategy
for 2030
This is an explanation of our strategy for maximizing corporate value based on our new Medium-Term Business Plan Beyond 2027 announced in June 2024.
- Japanese
generics business - New
businesses - Human asset strategy (message from the General Manager of the Human Resource Department)
- Financial strategy (message from the General Manager of the Finance Department)
- Medium-term Business Plan
- Environment
- Related webpages
Governance
Constructing
a fair, transparent
management system
We will enhance medium- to long-term corporate value by continuing to reinforce our management system and appropriately and quickly responding to changes in the external environment.
- Related webpages
Always putting
healthier lives first
The Sawai Group Holdings’ corporate philosophy of “always putting healthier lives first” embodies our desire to contribute to the health of as many people as possible as a healthcare corporate group which develops sustainably alongside society with the generic drugs business as our core business. We will mobilize the strengths of all Group employees to pursue the challenge of meeting the expectations of all stakeholders.
Download all pages
- For printing (A4-size)
All single pages PDF (7.7MB) - For viewing (A3-size)
All facing pages PDF (10.5MB)
Download in sections
Download separate volume of Financial section
- For printing (A4-size)
All single pages PDF (2.4MB) - For viewing (A3-size)
All facing pages PDF (0.8MB)
Back issues
- Year Ended March 31, 2023
- Year Ended March 31, 2022
- Year Ended March 31, 2021
- Year Ended March 31, 2020
- Year Ended March 31, 2019
- Year Ended March 31, 2018
- Year Ended March 31, 2017
- Year Ended March 31, 2016
- Year Ended March 31, 2015
- Year Ended March 31, 2014
- Year Ended March 31, 2013
- Year Ended March 31, 2012
- Year Ended March 31, 2011
- Year Ended March 31, 2010
- Year Ended March 31, 2009
- Year Ended March 31, 2008
- Year Ended March 31, 2007
- Year Ended March 31, 2006
- Year Ended March 31, 2005
- Year Ended March 31, 2004
- Year Ended March 31, 2003
- Year Ended March 31, 2002
- Year Ended March 31, 2001
- Year Ended March 31, 2000